Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers evaluating safety, tolerability, and pharmacokinetics of multiple doses of AV-101 has been completed, providing initial safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• AV-101

Snippet

Sponsor: VistaGen Therapeutics, Inc. | Conditions: Neuropathic Pain | Phase 1 | Status: COMPLETED